METHODS AND COMPOSITIONS FOR TREATING AND MONITORING TREATMENT OF IL-13-ASSOCIATED DISORDERS

摘要

Methods and compositions for reducing or inhibiting, or preventing or delaying the onset of, one or more symptoms associated with an early and/or a late phase of an IL- 13-associated disorder or condition using IL- 13 binding agents are disclosed. Methods for evaluating the kinetics and/or efficacy of an IL- 13 binding agent in treating or preventing an IL- 13 -associated disorder or condition in a subject, e.g., a human subject, are also disclosed.